João Luiz Langer Manica Mariana Diligenti ... - Genética - ufcspa

43. Nicolaides KH, Brizot ML, Snijders RJ. Fetal nuchal translucency: ultrasound
screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol
101(9):782-6, 1994.
44. Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH. Screening for trisomy 13
by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14
weeks of gestation. Prenat Diagn 20(5):411-6, 2000.
45. Bersinger NA, Brizot ML, Johnson A, Snijders RJ, Abbot J, Schneider H,
Nicolaides KH. First trimester maternal serum pregnancy-associated plasma protein A
and pregnancy-specific beta 1-glycoprotein in fetal trisomies. Br J Obstet Gyanecol
101(11):970-4, 1994.
46. Yaron Y, Krivchenia E, Cole LA, Leon J, Reineke E, Evans MI. Urinary beta-core
fragment (BCF) of human chorionic gonadotropin (hCG) as a predictor of trisomy 13
and trisomy 18. Am J Obstet Gynecol 178:146-147, 1998.
47. Yang CF, Tsai FJ, Wu JY, Shi YR, Lee CC, Tsa CH. Rapid diagnosis of comom
aneuploidies by quantitative fluorescent polymerase chain reaction. Taiwan Erh Ko I
Hsueh Hui Tsa Chih 40(5):330-4, 1999.
48. Isada NB, Hume RF, Reichler A, Johnson MP, Klinger KW, Evans MI, Ward BE.
Fluorescent in situ hybridization and second-trimester sonographic anomalies: uses and
limitations. Fetal Diagn Ther 9(6):367-70, 1994.
ANEXO:
34